3Yeh RW,Ponce de Leon A,Agasino CB,et al.Stability of Mycobacterium tuberculosis DNA genotypes.J Infect Dis,1998,177:1107-1111.
4Alito A,Morcillo N,Scipioni S,et al.The IS6110 restriction fragment length polymorphism in particular multidrug-resistant Mycobacterium tuberculosis strains may evolve too fast for reliable use in outbreak investigation.J Clin Microbiol,1999,37:788-791.
5de Boer AS,Borgdorff MW,de Haas PE,et al.Analysis of rate of change of IS6110 RFLP patterns of Mycobacterium tuberculosis based on serial patient isolates.J Infect Dis,1999,180:1238-1244.
6Warren RM,van der Spuy GD,Richardson M,et al.Calculation of the stability of the IS6110 banding pattern in patients with persistent Mycobacterium tuberculosis disease.J Clin Microbiol,2002,40:1705-1708.
7Kremer K,Glynn JR,Lillebaek T,et al.Definition of the Beijing/W lineage of Mycobacterium tuberculosis on the basis of genetic markers.J Clin Microbiol,2004,42:4040-4049.
8Mazars E,Lesjean S,Banuls AL,et al.High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology.Proc Natl Acad Sci U S A,2001,98:1901-1906.
10Hong Kong Chest Service/British Medical Research Council.Controlled trial of 2,4,and 6 months of pyrazinamide in 6-month,three-times-weekly regimens for smear-positive pulmonary tuberculosis,including an assessment of a combined preparation of isoniazid,rifampin,and pyrazinamide.Results at 30 months.Am Rev Respir Dis,1991,143:700-706.
